Phare Bio is an ambitious new social venture using novel AI and deep learning for antimicrobial development in partnership with Jim Collins' lab at MIT. Started in 2021 to address a looming crisis in antibiotic resistance, Phare is the recipient of Audacious Project prize to support big and potentially powerful solutions to the world's most urgent challenges.